JBLU heads into the summer travel season with a curious split: the stock is up 6% on the week and 14% over the past month, yet short sellers are adding exposure rather than covering.
The short interest angle is the defining tension this week. Bearish positioning jumped roughly 13% over the past seven trading days, pushing short interest to nearly 20% of free float — a level that ranks among the more heavily shorted names in the airline sector. The move is not a market-wide tightening; it is specific to JetBlue. Around 71.5 million shares are now estimated short, up from roughly 63.4 million just over a week ago. What makes this particularly notable is that it happened into price strength, not into a falling stock — shorts are not defending existing profits, they are opening new ones. The ORTEX short score holds near 61, a reading that places JetBlue in the bottom quarter of the universe on this metric, and it has barely budged over the past two weeks, suggesting the bearish thesis is entrenched rather than reactive.
The borrow market, however, does not corroborate a squeeze setup. Availability is running at roughly 259% — meaning nearly two-and-a-half times as many shares remain available to borrow as are currently shorted — well above the 52-week trough of 111%. Borrowing costs are also negligible at 0.47% annualised, essentially unchanged on the week and among the lowest in the sector. With so much lending capacity still in the pool, any near-term mechanical pressure on shorts is limited. Options traders are similarly relaxed: the put/call ratio of 0.72 sits fractionally below its 20-day average of 0.74, and the z-score of -0.58 signals no unusual defensiveness — the options market is not corroborating the short sellers' conviction.
The Street's positioning tells a sceptical story on JetBlue's recovery prospects. The most recent analyst action, from UBS in late May, raised the target from $3.50 to $4.00 while maintaining a Sell rating — a modest lift that still implies meaningful downside from the current $5.22 price. Goldman Sachs lowered its target to $3.50 in April and held its Sell. Citigroup trimmed to $4.40 and is neutral. The consensus mean target of roughly $4.95 sits below the current price — an unusual setup that effectively means the aggregate Street view is that the stock has already overshot fair value. Valuation provides little comfort: EV/EBITDA has compressed by roughly 3 turns over the past month to 13.8x, and the earnings yield is negative. The 90-day EPS momentum factor ranks in the 96th percentile — the best-in-class reading on the scorecard — suggesting forward estimates have been revised sharply higher, but quality metrics remain deeply negative, with the short score rank sitting in the bottom 11% of the universe.
Institutional ownership adds an intriguing layer. Icahn Capital trimmed its stake by roughly 3.9 million shares as recently as June 9, reducing to around 20.7 million shares, or 5.6% of the company. BlackRock added modestly in the same period. The insider picture is less alarming than the headline net figure suggests — the 90-day net of 423,802 shares in favour of buying is almost entirely driven by a stock award to President Joanna Geraghty, which was accompanied by an open-market sale of 135,873 shares at $5.38. Other recent transactions from directors and officers were small and predominantly on the sell side.
Peer context sharpens the contrast. AAL gained 11.5% on the week and ALGT 10.6%, both outpacing JetBlue's 6.1% move. DAL and ULCC lagged the group, each up around 2.5%. JetBlue lands in the middle of its peer set on price performance — not the standout recovery trade, but not the laggard either. That middling outcome, set against short interest at almost 20% of float, frames the key tension heading into July 28 earnings: the next quarterly print will need to show that the cost-cutting initiatives and recovering summer load factors are translating into tangible progress, or the short case — rebuilt aggressively into this rally — will look well-positioned.
See the live data behind this article on ORTEX.
Open JBLU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
